Summary
The cardiovascular diagnostic device market was valued at $10,534.0 million in 2024 and is estimated to reach $21,134.05 million by 2034, exhibiting a CAGR of 7.2% from 2025 to 2034. Cardiovascular diagnostics refers to the medical tools used to detect, and assess conditions affecting the heart and blood vessels. These diagnostics are critical in identifying cardiovascular diseases (CVDs) such as arrhythmias, coronary artery disease, heart failure, and structural heart abnormalities. Devices such as electrocardiogram (ECG) systems, Holter monitors, cardiac patch monitors, event recorders, and implantable loop recorders enable healthcare professionals to capture and analyze electrical signals of the heart, detect irregular rhythms, and track cardiac activity over time.
The main objective of cardiovascular diagnostics is early and accurate identification of heart-related conditions, which is vital for timely intervention and effective management. These diagnostics not only help in acute settings but also play an essential role in long-term monitoring, post-surgical care, and preventive cardiology. As cardiovascular diseases remain the leading cause of global mortality, the demand for advanced, portable, and user-friendly diagnostic technologies continues to grow, especially with the increasing focus on remote monitoring and personalized care.
The major factor driving the cardiovascular diagnostics device market is the increasing global burden of cardiovascular diseases (CVDs). For instance, according to the U.S. Department of Health & Human Services about 1 in 20 adults age 20 and older have coronary heart disease and someone has a heart attack every 40 seconds. This increasing burden is creating an increased demand for early and accurate diagnosis, thereby propelling the adoption of ECG systems, Holter monitors, and other advanced cardiac diagnostic tools.Furthermore, innovations in cardiac diagnostic devices such as wireless connectivity, cloud-based data storage, and AI-powered analytics are revolutionizing cardiac care. The introduction of portable ECG devices, smartphone compatible Holter monitors, and wearable cardiac patches has improved patient compliance and enabled real time monitoring. These advancements enhance diagnostic accuracy, reduce hospital visits, and support remote patient management, driving widespread adoption.In addition, healthcare systems are thereby shifting toward preventive care to reduce the cost and burden of chronic diseases.
Remote and continuous monitoring are gaining traction, especially post-COVID-19, as patients and providers seek safe, contactless diagnostic options. Cardiac patch monitors and implantable loop recorders enable long term rhythm tracking in at-risk patients, making them vital in early diagnosis and management of arrhythmias and other cardiovascular conditions.However, the high initial cost of advanced cardiovascular diagnostic devices and limited reimbursement in certain regions can restrict their adoption, especially in low and middle income countries. Hospitals and clinics with limited budgets may be hesitant to invest in these tools, while patients may avoid testing due to out-of-pocket expenses. These financial barriers can hinder market growth in cost-sensitive healthcare systems.
Moreover, emerging economies in Asia-Pacific, LAMEA offer significant growth potential due to improving healthcare infrastructure, rising disposable incomes, and growing awareness of cardiovascular health. and user-friendly diagnostic devices, presents an opportunity for market players to tap into a broader patient base through direct-to-consumer and telehealth channels.
The cardiovascular diagnostics device market is segmented into product, end user, distribution channel, and region. By product, the market is categorized into electrocardiogram devices, Holter monitoring devices and others. On the basis of end user, it is segregated into hospitals, cardiac centers, and others. Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global cardiovascular diagnostics market are Medtronic plc, Koninklijke Philips N.V., VitalConnect, Abbott Laboratories, GE Healthcare, Boston Scientific Corporation, Nihon Kohden Corporation, Schiller AG, Baxter International Inc., and Biotronik.
Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cardiovascular diagnostic device market analysis from 2024 to 2034 to identify the prevailing cardiovascular diagnostic device market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the cardiovascular diagnostic device market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global cardiovascular diagnostic device market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Patient/epidemiology data at country, region, global level
● Regulatory Guidelines
● Additional company profiles with specific to client's interest
● Additional country or region analysis- market size and forecast
● Expanded list for Company Profiles
● Historic market data
● SWOT Analysis
Key Market Segments
By Type
● Electrocardiogram devices
● Holter monitoring devices
● Others
By End User
● Hospitals
● Cardiac Centers
● Others
By Distribution Channel
● Online
● Offline
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ South Africa,
○ Saudi Arabia
○ Rest of LAMEA
● Key Market Players
○ Boston Scientific Corporation
○ Abbott Laboratories
○ Nihon Kohden Corporation
○ Baxter International Inc.
○ Biotronik SE & Co. KG
○ Schiller
○ Koninklijke Philips N.V.
○ VitalConnect
○ GE HealthCare
○ Medtronic plc
ページTOPに戻る
Table of Contents
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rising burden of cardiovascular diseases globally
3.4.1.2. Advancements in wearable and remote monitoring technologies
3.4.1.3. Growing preference for early and preventive cardiac diagnosis
3.4.2. Restraints
3.4.2.1. High cost and reimbursement limitations
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
CHAPTER 4: CARDIOVASCULAR DIAGNOSTIC DEVICE MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Electrocardiogram devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Holter monitoring devices
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Others
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: CARDIOVASCULAR DIAGNOSTIC DEVICE MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Cardiac Centers
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: CARDIOVASCULAR DIAGNOSTIC DEVICE MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Online
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Offline
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: CARDIOVASCULAR DIAGNOSTIC DEVICE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by End User
7.2.4. Market size and forecast, by Distribution Channel
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Type
7.2.5.1.2. Market size and forecast, by End User
7.2.5.1.3. Market size and forecast, by Distribution Channel
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Type
7.2.5.2.2. Market size and forecast, by End User
7.2.5.2.3. Market size and forecast, by Distribution Channel
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Type
7.2.5.3.2. Market size and forecast, by End User
7.2.5.3.3. Market size and forecast, by Distribution Channel
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by End User
7.3.4. Market size and forecast, by Distribution Channel
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Type
7.3.5.1.2. Market size and forecast, by End User
7.3.5.1.3. Market size and forecast, by Distribution Channel
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Type
7.3.5.2.2. Market size and forecast, by End User
7.3.5.2.3. Market size and forecast, by Distribution Channel
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Type
7.3.5.3.2. Market size and forecast, by End User
7.3.5.3.3. Market size and forecast, by Distribution Channel
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Type
7.3.5.4.2. Market size and forecast, by End User
7.3.5.4.3. Market size and forecast, by Distribution Channel
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Type
7.3.5.5.2. Market size and forecast, by End User
7.3.5.5.3. Market size and forecast, by Distribution Channel
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Type
7.3.5.6.2. Market size and forecast, by End User
7.3.5.6.3. Market size and forecast, by Distribution Channel
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by End User
7.4.4. Market size and forecast, by Distribution Channel
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Market size and forecast, by Type
7.4.5.1.2. Market size and forecast, by End User
7.4.5.1.3. Market size and forecast, by Distribution Channel
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by Type
7.4.5.2.2. Market size and forecast, by End User
7.4.5.2.3. Market size and forecast, by Distribution Channel
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Type
7.4.5.3.2. Market size and forecast, by End User
7.4.5.3.3. Market size and forecast, by Distribution Channel
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Type
7.4.5.4.2. Market size and forecast, by End User
7.4.5.4.3. Market size and forecast, by Distribution Channel
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Type
7.4.5.5.2. Market size and forecast, by End User
7.4.5.5.3. Market size and forecast, by Distribution Channel
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Type
7.4.5.6.2. Market size and forecast, by End User
7.4.5.6.3. Market size and forecast, by Distribution Channel
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by End User
7.5.4. Market size and forecast, by Distribution Channel
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Type
7.5.5.1.2. Market size and forecast, by End User
7.5.5.1.3. Market size and forecast, by Distribution Channel
7.5.5.2. South Africa,
7.5.5.2.1. Market size and forecast, by Type
7.5.5.2.2. Market size and forecast, by End User
7.5.5.2.3. Market size and forecast, by Distribution Channel
7.5.5.3. Saudi Arabia
7.5.5.3.1. Market size and forecast, by Type
7.5.5.3.2. Market size and forecast, by End User
7.5.5.3.3. Market size and forecast, by Distribution Channel
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Type
7.5.5.4.2. Market size and forecast, by End User
7.5.5.4.3. Market size and forecast, by Distribution Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2024
CHAPTER 9: COMPANY PROFILES
9.1. Medtronic plc
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Boston Scientific Corporation
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Koninklijke Philips N.V.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Abbott Laboratories
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Nihon Kohden Corporation
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Schiller
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Key strategic moves and developments
9.7. VitalConnect
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Key strategic moves and developments
9.8. Baxter International Inc.
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. Biotronik SE & Co. KG
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. GE HealthCare
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
